First Drug For Severe Alopecia Recommended By NICE Could Benefit 14,000 Patients

January 2024 in “ Pharmaceutical journal/The pharmaceutical journal ”

Ritlecitinib Litfulo Pfizer alopecia areata kinase inhibitor inflammation hair loss

TLDR Ritlecitinib can help about 14,000 people with severe hair loss.

The National Institute for Health and Care Excellence (NICE) has recommended Ritlecitinib (Litfulo; Pfizer), the first drug for treating severe alopecia areata in individuals aged 12 and over. This once-daily oral kinase inhibitor reduces enzymes responsible for inflammation and hair loss. It is estimated that this treatment could benefit approximately 14,000 patients.

View this study on dx.doi.org →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community Anyone else taking Litfulo (ritlecitinib) to treat their alopecia?

in Treatment 6 upvotes 2 years ago

A user diagnosed with Alopecia Areata started using Litfulo (ritlecitinib), kenalog shots, and mometasone furoate 0.1%. They shaved their head and are seeking others' experiences with Litfulo.

community Article of all potential future cures

in Treatment 25 upvotes 11 months ago

Ritlecitinib and PP405 show promise for hair regrowth. Diagnosing the cause of hair loss is crucial before treatment.

community An arthritis drug that can be used for Alopecia.

in Research/Science 4 upvotes 4 years ago

An arthritis drug, baricitinib, is discussed as a potential treatment for autoimmune alopecia, not androgenetic alopecia. Ritlecitinib is also mentioned as a possible treatment for scarring alopecia.

community Pyrilutamide available at Actifolic now

in Research/Science 15 upvotes 3 years ago

Pyrilutamide, a new hair loss product with the potential to be more effective than RU58841 and safer than CB, but expensive.

community Do People even realize that we got a new Treatment Option and Kintor Officially released Pyrilutamide?

in Treatment 56 upvotes 1 year ago

A new hair loss treatment, Pyrilutamide, has been released and is claimed to be a strong anti-androgen, potentially effective when used with finasteride. However, there are mixed opinions on its effectiveness and safety, with some users skeptical and others purchasing it.

community pyrilutamide solution progress log

in Product 20 upvotes 3 years ago

A 28 year old using a hair loss prevention protocol to restore thinning hair, which includes finasteride, dutasteride, minoxidil, stemoxydine, alopecin, nizoral shampoo and microneedling; the user is now adding pyrilutamide solution to the regimen with the hope of improving their results. RU58841 was also ordered but not yet used.

Similar Research

5 / 1000+ results

research Ritlecitinib in severe alopecia areata: a profile of its use

September 2024 in “Drugs & Therapy Perspectives”

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

research Ritlecitinib: First Approval

84 citations , August 2023 in “Drugs”

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

The FDA Approves Litfulo® (Ritlecitinib) for the Treatment of Severe Alopecia Areata in Adolescents and Adults

research La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos

September 2023 in “Medicina Estética Revista Científica de la Sociedad Española de Medicina Estética (SEME)”

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

research ‘Ritlecitinib: unveiling hair regrowth for alopecia areata’

September 2024 in “Annals of Medicine and Surgery”

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

research Alopecia areata: Ritlecitinib generates substantial re-growth of scalp hair

October 2023